Pervasive chromosomal instability and karyotype order in tumour evolution

[1]  Angela E. Leek,et al.  Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution , 2020, Nature Genetics.

[2]  Nicholas D. Camarda,et al.  Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma , 2020, Nature Genetics.

[3]  Benjamin J. Raphael,et al.  Characterizing the allele- and haplotype-specific copy number landscape of cancer genomes at single-cell resolution with CHISEL , 2019 .

[4]  P. Scheet,et al.  Large-scale analysis of acquired chromosomal alterations in non-tumor samples from patients with cancer , 2019, Nature Biotechnology.

[5]  A. van Oudenaarden,et al.  Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids , 2019, Nature Genetics.

[6]  L. Terracciano,et al.  Convergent Evolution of Copy Number Alterations in Multi-Centric Hepatocellular Carcinoma , 2019, Scientific Reports.

[7]  Z. Szallasi,et al.  Neoantigen-directed immune escape in lung cancer evolution , 2019, Nature.

[8]  S. Sleijfer,et al.  Pan-cancer whole-genome analyses of metastatic solid tumours , 2018, bioRxiv.

[9]  Jack Cuzick,et al.  Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and death , 2018, eLife.

[10]  Sergi Elizalde,et al.  A Markov chain for numerical chromosomal instability in clonally expanding populations , 2018, PLoS Comput. Biol..

[11]  B. Taylor,et al.  Genome doubling shapes the evolution and prognosis of advanced cancers , 2018, Nature Genetics.

[12]  P. A. Futreal,et al.  Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.

[13]  Zoltan Szallasi,et al.  Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal , 2018, Cell.

[14]  Steven J. M. Jones,et al.  Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.

[15]  F. Foijer,et al.  Non-random Mis-segregation of Human Chromosomes , 2018, bioRxiv.

[16]  Samuel F. Bakhoum,et al.  Chromosomal instability drives metastasis through a cytosolic DNA response , 2017, Nature.

[17]  Angela E. Leek,et al.  Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution , 2017, Cell.

[18]  P. Lønning,et al.  Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.

[19]  Nicolai J. Birkbak,et al.  Tracking the Evolution of Non‐Small‐Cell Lung Cancer , 2017, The New England journal of medicine.

[20]  Ashwini Naik,et al.  Phylogenetic ctDNA analysis depicts early stage lung cancer evolution , 2017, Nature.

[21]  Jessica M. Rusert,et al.  Extrachromosomal oncogene amplification drives tumor evolution and genetic heterogeneity , 2017, Nature.

[22]  Stephane E. Castel,et al.  Rare variant phasing and haplotypic expression from RNA sequencing with phASER , 2016, Nature Communications.

[23]  A. Sablina,et al.  Loss of Chromosome 8p Governs Tumor Progression and Drug Response by Altering Lipid Metabolism. , 2016, Cancer cell.

[24]  Marc J. Williams,et al.  Identification of neutral tumor evolution across cancer types , 2016, Nature Genetics.

[25]  Sergi Elizalde,et al.  Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution. , 2015, Cell reports.

[26]  Andrew Menzies,et al.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.

[27]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[28]  C. Curtis,et al.  A Big Bang model of human colorectal tumor growth , 2015, Nature Genetics.

[29]  Evis Sala,et al.  Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.

[30]  Panagiotis Moulos,et al.  Systematic integration of RNA-Seq statistical algorithms for accurate detection of differential gene expression patterns , 2014, Nucleic acids research.

[31]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[32]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[33]  C. Sima,et al.  Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[34]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[35]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[36]  James D. Brenton,et al.  Phylogenetic Quantification of Intra-tumour Heterogeneity , 2013, PLoS Comput. Biol..

[37]  S. Elledge,et al.  Cumulative Haploinsufficiency and Triplosensitivity Drive Aneuploidy Patterns and Shape the Cancer Genome , 2013, Cell.

[38]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[39]  Z. Szallasi,et al.  Parallel evolution of tumour subclones mimics diversity between tumours , 2013, The Journal of pathology.

[40]  Eric Lim,et al.  Prognostic Significance of Predominant Histologic Pattern and Nuclear Grade in Resected Adenocarcinoma of the Lung: Potential Parameters for a Grading System , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[42]  Francesca Chiaromonte,et al.  A genome-wide analysis of common fragile sites: What features determine chromosomal instability in the human genome? , 2012, Genome research.

[43]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[44]  R. Jessberger.  'Exploring aneuploidy: the significance of chromosomal imbalance' review series , 2012 .

[45]  Y. Moreau,et al.  Single-cell copy number variation detection , 2011, Genome Biology.

[46]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[47]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[48]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[49]  P. Donnelly,et al.  A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies , 2009, PLoS genetics.

[50]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[51]  Z. Szallasi,et al.  A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.

[52]  L. Chin,et al.  Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.

[53]  David Pellman,et al.  Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells , 2005, Nature.

[54]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[55]  J. Hartigan,et al.  The Dip Test of Unimodality , 1985 .